Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches
While specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.
Source: hcplive.com